Finance

Lists
INTI:OTCMKTS
Inhibitor Therapeutics Inc
0,10 $
0,00%
(0,00) 1D
28 қыр., 09:30:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INTI...
Mkt. cap
17,38 млн
Avg. vol.
265,00
Volume
0,00
52-wk high
0,12 $
52-wk low
0,04 $
EPS
-0,02 $
Beta
-0,36
Shares outstanding
173,79 млн
No. of employees
5
Mkt. cap
17,38 млн
Avg. vol.
265,00
Volume
0,00
52-wk high
0,12 $
52-wk low
0,04 $
EPS
-0,02 $
Beta
-0,36
Shares outstanding
173,79 млн
No. of employees
5
News stories
From web sources and news partners
About Inhibitor Therapeutics Inc
CEO-
Employees5
Founded1992
HeadquartersТампа, Флорида, Америка Құрама Штаттары
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
377,79 м.
757,25 м.
340,56 м.
223,56 м.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
363,43 м.
557,87 м.
355,07 м.
395,03 м.
Operating expense
741,22 м.
1,32 млн
695,63 м.
618,60 м.
Total operating expenses
741,22 м.
1,32 млн
695,63 м.
618,60 м.
Operating income
-741,22 м.
-1,32 млн
-695,63 м.
-618,60 м.
Other non operating income
-
-
-
-
EBT including unusual items
-712,18 м.
-1,30 млн
-686,42 м.
-613,93 м.
EBT excluding unusual items
-712,18 м.
-1,30 млн
-686,42 м.
-613,93 м.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-712,18 м.
-1,30 млн
-686,42 м.
-613,93 м.
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
29,03 мың
19,75 мың
9,21 мың
4,66 мың
Interest expense
-
-
-
-
Net interest expenses
29,03 мың
19,75 мың
9,21 мың
4,66 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары